Transcend Therapeutics’ Phase II IMPACT-1 study examining its neuroplastigen treatment for post-traumatic stress disorder ...

Weeks after asking the Arizona Legislature to fund clinical trials for novel treatment for PTSD, former U.S. Sen. Kyrsten Sinema was hired by a Washington, D.C., law firm that represents a company ...

The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD: Ketamine Combined with Written Exposure Therapy” on ...

Divorce trauma can mirror PTSD, affecting emotions and the legal process. Learn how it impacts you and how to heal and move ...

New research reveals that fear of emotions may explain why individuals with PTSD symptoms often struggle to communicate with ...

A House committee has unanimously approved a bill to set up a state program for psilocybin, also known as “magic mushrooms,” ...

People with post-traumatic stress disorder (PTSD) symptoms often have trouble communicating and resolving relationship ...

Former Sen. Kyrsten Sinema told an Arizona House panel in February she's pushing for clinical trials on ibogaine as part of a "passion project." ...

Psilocybin, the psychoactive compound in “magic mushrooms,” could be administered to help treat post-traumatic stress ...

The International Institute for Brain Enhancement (IIBE) is proud to announce a groundbreaking partnership with NeuralCure AI ...

New York, April 02, 2025 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) invites the public to a free webinar, “Developing a Potential New Treatment for Chronic PTSD ...

Individuals with chronic post-traumatic stress disorder (PTSD) need effective and tolerable treatments, especially those with more severe and persistent symptoms. Dr. Feder's research focuses on the ...